Satoru Yamakawa

Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)

Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi et al. · Hypertension · 2019 · 185 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

Hiromi Rakugi, Sadayoshi Ito, Hiroshi Itoh et al. · Hypertension Research · 2019 · 70 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study

Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi et al. · Journal of Human Hypertension · 2019 · 64 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes

Kazuomi Kario, Sadayoshi Ito, Hiroshi Itoh et al. · Hypertension Research · 2021 · 37 citations · Full text

Medicine, Cardiology, Pharmacology +17

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A <i>Post Hoc</i> Analysis of the ESAX-HTN Study

Kazuomi Kario, Sadayoshi Ito, Hiroshi Itoh et al. · American Journal of Hypertension · 2020 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17